Strengthening Families & Communities, LLC
Position in VTVT — vTv Therapeutics Inc.
CIK 1921196
BOSTON, MA
Position in VTVT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,861
+$2,822 QoQ
Shares Held
173
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VTVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Strengthening Families & Communities, LLC holds $172,945 across 11 Biotechnology names. VTVT ranks #4 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
1,000 | $67,680 | |
| 2 | ACLX |
Arcellx, Inc.
|
500 | $57,410 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $18,543 | |
| 4 | VTVT |
vTv Therapeutics Inc.
This page
|
173 | $6,861 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13 | $5,805 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
150 | $4,881 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
79 | $4,462 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
60 | $2,854 |
All Filings in VTVT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,861 | 173 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $4,039 | 173 | Shares | Sole | 2025-11-04 | |
| 2024-09-30 | $2,346 | 173 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,055 | 173 | Shares | Sole | 2024-07-22 | |
| No filing history on record for this holder in this stock. | ||||||